Ethan Trim

1PUBLICATIONS
0CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 19, 2025
Immunotherapy Rechallenge Is Effective for Most Patients With Late Progression After Initial Ipilimumab + Nivolumab Response.

Ethan Trim, Anita Giobbie-Hurder, Tamara A Sussman

Pageof 1

Frequent Collaborators